Caption Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 893 |
|
2025
Q1 | – | Sell |
-53,844
| Closed | -$1.01M | – | 948 |
|
2024
Q4 | $1.01M | Buy |
+53,844
| New | +$1.01M | 0.01% | 202 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 759 |
|
2024
Q2 | – | Sell |
-48,598
| Closed | -$1.42M | – | 718 |
|
2024
Q1 | $1.42M | Buy |
48,598
+35,900
| +283% | +$1.05M | 0.02% | 129 |
|
2023
Q4 | $428K | Sell |
12,698
-13,302
| -51% | -$449K | 0.01% | 230 |
|
2023
Q3 | $798K | Buy |
26,000
+6,800
| +35% | +$209K | 0.01% | 171 |
|
2023
Q2 | $769K | Buy |
+19,200
| New | +$769K | 0.01% | 155 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 812 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 865 |
|
2021
Q1 | – | Sell |
-10,833
| Closed | -$648K | – | 660 |
|
2020
Q4 | $648K | Buy |
10,833
+833
| +8% | +$49.8K | 0.01% | 150 |
|
2020
Q3 | $600K | Buy |
+10,000
| New | +$600K | 0.01% | 173 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 544 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 505 |
|